Filter by
- Algeria (2)
- Angola (2)
- Benin (2)
- Botswana (3)
- Burkina Faso (4)
- Burundi (5)
- Cabo Verde (5)
- Cameroon (2)
- Central African Republic (1)
- Chad (2)
- Cote d'Ivoire (2)
- Democratic Republic of the Congo (5)
- Equatorial Guinea (5)
- Eritrea (1)
- Eswatini (2)
- Ethiopia (6)
- Gabon (1)
- Gambia (3)
- Ghana (4)
- Guinea (4)
- Guinea-Bissau (2)
- Kenya (11)
- Lesotho (1)
- Madagascar (1)
- Malawi (2)
- Mali (2)
- Mauritania (2)
- Mauritius (4)
- Mozambique (10)
- Namibia (3)
- Niger (11)
- Nigeria (3)
- Rwanda (5)
- Sao Tome and Principe (1)
- Senegal (3)
- Sierra Leone (3)
- South Africa (1)
- South Sudan (2)
- Uganda (4)
- United Republic of Tanzania (5)
- Zambia (1)
- Zimbabwe (2)
- Codes not specific to health (18)
- Health and care workforce (201)
- Health facilities, service delivery (90)
- Health Information Systems (101)
- Health Insurance, Social Protection (100)
- (-) Health products (119)
- Institutions and mandate (128)
- Protection of specific groups (43)
- Public Health (86)
- Social determinants of health (3)
- Specific health area or disease (68)
Arrêté No 68/MSP/DGSP/DPHLMT, portant création de la Commission Nationale du Médicament (CNM)
The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.
Essential drug list
These guidelines establish an Essential Drug List of Botswana of 2012 and provide the requirements regarding the levels of availability across health care providers.
Décret n°2012-966/PRES/PM/MS/MEF/MICA/MRSI portant adoption d'une politique pharmaceutique 2012-2016
The decree establishes the pharmaceutical policy in Burkina Faso. The Pharmaceutical Policy is a national planning framework that expresses the government's vision, goals, objectives and strategic interventions for the development of the pharmaceutical sector. The policy aims to improve access to quality healthcare products, available throughout the country at a cost adapted to the population's purchasing power.
Standard Treatment Guidelines and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland
This document provides for standard treatment guidelines and the essential medicines list.
Guidelines for prevention of mother to child transmission of HIV/AIDS in Kenya 4th edition
The Revised Guidelines (4th edition) for Prevention of Mother-to-Child Transmission (PMTCT) of HIV and AIDS provide more detailed and effective interventions to reduce the risk of mother-to-child transmission (MTCT) than previous editions. They emphasize the early initiation of ARV prophylaxis starting at 14 weeks, highlighting the importance of early antenatal care (ANC) attendance for all women.
Arrêté No 466/MSP/DGSP/DPHL/MT, portant additif à l’arrêté n° 065/MSP/DGSP/DPHL/MT du 09 février 2009 portant Liste Nationale des Médicaments essentiels (LNME)
The decree revises Niger's national list of essential medicines from 2009
Drug and Food Control Authority Act, No 37
This Act provides for the establishment of an independent Drug and Food Control Authority in South Sudan and provide an appropriate and effective independent regulatory mechanism to control and regulate the manufacture, supply, promotion, marketing, advertising, distribution and use of drugs, poisons, chemicals, cosmetics medical devices and food for human or animal use.
Guidelines for antiretroviral therapy in Kenya
These guidelines outline standardized protocols for the initiation and management of HIV treatment, emphasizing early treatment initiation and adherence to improve health outcomes. They incorporate recommendations for monitoring treatment efficacy, managing side effects, and addressing co-infections, ensuring a patient-centered approach in diverse healthcare settings.
Clinical Trials Act
This Act regulates the conduct of clinical trials for medicinal products in Mauritius.
Decreto presidencial No 180/10 as bases gerais da política nacional farmacêutica
The Decree establishes the General Bases of the National Pharmaceutical Policy.
National Guidelines for HIV testing and counselling in Kenya
These Guidelines outline standardized protocols for voluntary testing and counselling to enhance access to HIV services, ensure informed consent, and promote client confidentiality and support.
National Quality Management Guidance Framework for HIV Testing and Counseling in Kenya
This Guidance Framework outlines strategies and standards to ensure high-quality, client-centered HIV testing and counselling services, promoting accuracy, safety, and confidentiality in the process.
Loi No 2010-022 du 10 février 2010 relative a la pharmacie
This Law defines the legal provisions relating to medicines, medical devices, other health products and the practice of pharmacy in the Islamic Republic of Mauritania. This Law is published in a collection of other legislative acts and can be found on page 3 of the file.
Diploma Ministerial No 223/2010 Aprova o Manual de Registo de Medicamentos
The Diploma approves the Medicines Registration Manual. The purpose of the Manual is to (a) Standardize the procedures and activities relating to the registration of medicines; (b) Clarify the doubts that professionals have encountered when interpreting the Registration Regulations; (c) Support professionals in the field in carrying out their daily activities in a standardized way; (d) Support applicants in complying with registration and post-registration procedures; (e) to make the registration process an optimized and increasingly swift process.
Règlement No 06/2010/CM/UEMOA relatif aux procédures d’homologation des produits pharmaceutiques à usage humain
The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.
Décret n° 2009-720/PRES/PM/MS/MEF/MCPEA portant conditions de fabrication et d'importation des produits contraceptifs au Burkina Faso
The Decree sets out the conditions for manufacturing and importing contraceptive products into Burkina Faso.
Liste Nationale des médicaments essentiels en République Centrafricaine
This document establishes a National List of Essential Medicines in the Central African Republic.
Food, Medicine and Health Care Administration and Control Proclamation No. 661/2009
This Proclamation regulates activities in respect of food, medicine, environmental health, health professionals, health and controllable health related institutions in the country.
Ordonnance 056/2009/PRG/SGG relative à la Prevention, Prise en charge et le Contrôle du VIH/sida
The law regulates the management and control of HIV/AIDS in the Republic of Guinea.
HIV/AIDS decentralization guidelines
These Guidelines outline a framework for transferring HIV/AIDS service delivery responsibilities from central to local levels, promoting community involvement and improving access to care.